Xiong, Ph., Zhang, L., Tian, Sf. et al. Effect of equiguard in treating patients with Shen-yang deficiency syndrome., Chin. J. Integr. Med. 14, 225–227 (2008). https://doi.org/10.1007/s11655-007-9007-1
Pei-hua Xiong, Ling Zhang, Shou-fu Tian, et al. Effect of equiguard in treating patients with Shen-yang deficiency syndrome. [J]. Chinese Journal of Integrative Medicine 14(3):225-227(2008)
Xiong, Ph., Zhang, L., Tian, Sf. et al. Effect of equiguard in treating patients with Shen-yang deficiency syndrome., Chin. J. Integr. Med. 14, 225–227 (2008). https://doi.org/10.1007/s11655-007-9007-1DOI:
Pei-hua Xiong, Ling Zhang, Shou-fu Tian, et al. Effect of equiguard in treating patients with Shen-yang deficiency syndrome. [J]. Chinese Journal of Integrative Medicine 14(3):225-227(2008) DOI: 10.1007/s11655-007-9007-1.
Effect of equiguard in treating patients with Shen-yang deficiency syndrome
摘要
To observe the therapeutic effect of Equiguard in old patients with Shen (肾)-yang deficiency syndrome (SYDS). Twenty old patients with diagnosis matching the criteria of SYDS selected from out-patients were administered with Equiguard capsule 3 times per day
0.70 g each time for 3 successive months. The changes in general condition
peripheral blood picture
function of the liver and kidney
and sex hormones before and after treatment were observed. The changes in the American Urinary Surgery Association (AUA) score of prostatism
urosis and residue urine in the urinary bladder were also estimated. After the 3-month treatment
no significant change was found in the patients’ general condition
peripheral blood picture
liver and kidney function and sex hormones
while the symptoms of prostatism and urosis were markedly improved (P<0.01)
and the volume of residue urine in the urinary bladder was obviously reduced. Equiguard shows a significant therapeutic effect in treating old patients with SYDS
which could effectively improve the symptoms of prostatism and urosis in patients and is highly safe.
Abstract
To observe the therapeutic effect of Equiguard in old patients with Shen (肾)-yang deficiency syndrome (SYDS). Twenty old patients with diagnosis matching the criteria of SYDS selected from out-patients were administered with Equiguard capsule 3 times per day
0.70 g each time for 3 successive months. The changes in general condition
peripheral blood picture
function of the liver and kidney
and sex hormones before and after treatment were observed. The changes in the American Urinary Surgery Association (AUA) score of prostatism
urosis and residue urine in the urinary bladder were also estimated. After the 3-month treatment
no significant change was found in the patients’ general condition
peripheral blood picture
liver and kidney function and sex hormones
while the symptoms of prostatism and urosis were markedly improved (P<0.01)
and the volume of residue urine in the urinary bladder was obviously reduced. Equiguard shows a significant therapeutic effect in treating old patients with SYDS
which could effectively improve the symptoms of prostatism and urosis in patients and is highly safe.
关键词
EquiguardShen-yang deficiencyClinical Observation
Keywords
EquiguardShen-yang deficiencyClinical Observation
references
He ZG. Traditional Chinese Medicine. 4th ed. Beijing: People’s Medical Publishing House, 1996:68.
Mebust W, Roizo R, Schroeder F, et al. Correlations between pathology, clinical symptoms and the course of the disease. In: Cockett ATK, Aso Y, Chatelain C, eds. Proceedings of the international consultation on benign prostatic hyperplasia. Geneva: WHO, 1991:51.
Shen ZY. Study of kidney (Continuation). Shanghai: Shanghai Scientific and Technical Publishers, 1990:313.
Chen DW, Meng YC, Fang XJ, et al. The progress and prospect of modern medical of Kidney Yang Vacuity pattern. Mod J Integr Tradit Chin West Med (Chin) 2005;14(23):3175–3177.
Liu FC. Role of Desertliving Cistanche in the DNA synthesis of kidney-yang deficiency animal caused by epimedium herb and hydroxyacrbamide. Chin J Integr Tradit West Med 1984;4(8):488.
Chen RQ. Effect of Epimedium grandiflorum and FUZI on sodium activity in erythrocyte membrane in rat. J Shanghai Univ 1986;13(5):387.
Liu SR. Progress of pharmacological study. Inform Tradit Chin Med (Chin) 1992;9(3):15.